Related Experiment Video
Updated: Aug 14, 2026

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate
Published on: September 18, 2013
Abnormalities of protein kinases in neurodegenerative diseases
Abstract:
In neurodegenerative diseases such as ALS and AD there is evidence for abnormal regulation of protein kinases. In these diseases, altered activities and protein levels of several specific kinases suggest that abnormal phosphorylation is present and this aberrant phosphorylation may be involved in the pathogenesis of these diseases. The observation that regulation of the NMDA receptor ion channel is altered in tissue from ALS patients may arise from the abnormal phosphorylation state of the protein kinase regulating NMDA receptor function. Whether the abnormalities of these protein kinases is a primary event leading to altered receptor regulation or vice versa is still poorly understood. The seemingly multiple pathogenic mechanisms of ALS and AD create complexity in assessing a primary cause that may lead to cell death. The mechanisms causing cell death (apoptosis or necrosis) may be overlapping with integrated events among the components interacting and contributing to a final pathway for neuron death. Thus, evidence of impairment in protein kinase signalling in these diseases may be a primary cause, a secondary event, or a compensatory mechanism. To further study this issue, different model systems could be beneficial to obtain a better understanding of these diseases.
Insights
Protein kinase dysregulation in neurodegenerative diseases like ALS and AD may cause abnormal phosphorylation, potentially driving disease progression. Further research using model systems is crucial for understanding these complex mechanisms.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Neurodegenerative diseases, including Amyotrophic Lateral Sclerosis (ALS) and Alzheimer's Disease (AD), exhibit evidence of abnormal protein kinase regulation.
- Altered kinase activity and protein levels in these diseases suggest aberrant phosphorylation, a potential contributor to pathogenesis.
- Dysfunctional NMDA receptor regulation in ALS patients may stem from altered phosphorylation of associated protein kinases.
Purpose of the Study:
- To investigate the role of protein kinase signaling in the pathogenesis of neurodegenerative diseases like ALS and AD.
- To elucidate the relationship between protein kinase abnormalities and NMDA receptor function in ALS.
- To explore the complexity of pathogenic mechanisms and cell death pathways in ALS and AD.
Main Methods:
- Review of existing evidence on protein kinase regulation in neurodegenerative diseases.
- Analysis of altered kinase activities and protein levels.
- Consideration of NMDA receptor function in ALS patient tissue.
- Discussion of potential model systems for further study.
Main Results:
- Evidence suggests abnormal protein kinase regulation and aberrant phosphorylation in ALS and AD.
- Altered NMDA receptor regulation in ALS may be linked to aberrant phosphorylation.
- The precise role of kinase abnormalities (primary, secondary, or compensatory) remains unclear.
- Pathogenic mechanisms and cell death pathways in ALS and AD are complex and potentially overlapping.
Conclusions:
- Impaired protein kinase signaling is implicated in neurodegenerative diseases, but its exact role is debated.
- Understanding the interplay between protein kinases, NMDA receptors, and cell death is critical.
- Further investigation using diverse model systems is necessary to unravel the complexities of ALS and AD pathogenesis.
More Related Videos
Related Concept Videos
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Neural Regulation
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Parkinson's Disease: Overview
Alzheimer Disease ll: Pathophysiology
Parkinson Disease ll: Pathophysiology

